SRC and disorder of sexual differentiation: The targets listed are TP53, EGFR, AKT1, IL6, TNF, STAT3, IL1B, CTNNB1, SRC, MYC, JUN, and INS, which are likely to be the primary focus of DSD in the treatment of MI.